Stuttgart - Delayed Quote • EUR
Swedish Orphan Biovitrum AB (B6E.SG)
At close: April 26 at 3:46 PM GMT+2
Loading Chart for B6E.SG
DELL
- Previous Close
23.78 - Open
23.68 - Bid 23.86 x 100000
- Ask 24.16 x 100000
- Day's Range
23.54 - 23.92 - 52 Week Range
16.10 - 26.06 - Volume
0 - Avg. Volume
12 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: B6E.SG
Performance Overview: B6E.SG
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
B6E.SG
1.33%
OMX Stockholm 30 Index
6.65%
1-Year Return
B6E.SG
7.94%
OMX Stockholm 30 Index
13.72%
3-Year Return
B6E.SG
75.56%
OMX Stockholm 30 Index
14.13%
5-Year Return
B6E.SG
33.09%
OMX Stockholm 30 Index
51.39%
Compare To: B6E.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
23.76
-0.08%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
73.26
+1.57%
Mkt Cap 7.718B
Industry Drug Manufacturers—Specialty & Generic
Statistics: B6E.SG
Valuation Measures
As of 4/26/2024
Market Cap
8.18B
Enterprise Value
9.78B
Trailing P/E
43.92
Forward P/E
28.49
PEG Ratio (5yr expected)
1.79
Price/Sales (ttm)
4.00
Price/Book (mrq)
2.63
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
1.34
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: B6E.SG
B6E.SG does not have Company Insights